China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 61,697 | 50,969 | 33,186 | 21,843 | 8,658 |
| Cost of Goods | 36,046 | 25,678 | 17,619 | 11,746 | 4,167 |
| Gross Profit | 25,650 | 25,290 | 15,567 | 10,098 | 4,491 |
| Operating Expenses | 3,082 | 6,238 | 3,935 | 2,220 | 414 |
| Operating Income | 22,615 | 19,730 | 12,251 | 8,624 | 4,244 |
| Interest Expense | 154 | 131 | 237 | 146 | 187 |
| Other Income | -2,225 | -58 | 643 | 110 | -6 |
| Pre-tax Income | 20,235 | 19,541 | 12,657 | 8,587 | 4,052 |
| Income Tax | 2,262 | 1,708 | -163 | N/A | 252 |
| Net Income Continuous | 17,974 | 17,834 | 12,820 | 8,587 | 3,800 |
| Net Income | $17,974 | $17,834 | $12,820 | $8,587 | $3,800 |
| EPS Basic Total Ops | 215.00 | 220.00 | 175.00 | 125.00 | 170.00 |
| EPS Basic Continuous Ops | 212.56 | 221.72 | 173.19 | 123.65 | 168.29 |
| EPS Diluted Total Ops | 215.00 | 220.00 | 170.00 | 125.00 | 170.00 |
| EPS Diluted Continuous Ops | 212.56 | 221.72 | 172.03 | 123.65 | 168.29 |
| EBITDA(a) | $23,983 | $20,450 | $12,674 | $9,021 | $4,580 |